Please assess the completion status of the following clinical trial:

Trial Title: Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Metastatic nonseminomatous germ cell tumor of the testis~  * In first relapse following first line treatment with bleomycin, etoposide, and cisplatin~ * Biopsy proven germ cell tumor OR~ * Rising tumor markers (alpha fetoprotein and/or human chorionic gonadotropin)~* No brain metastases~PATIENT CHARACTERISTICS:~Age:~* 16 to 64~Performance status:~* 0-2~Life expectancy:~* Not specified~Hematopoietic:~* Not specified~Hepatic:~* Not specified~Renal:~* Glomerular filtration rate greater than 50 mL/min~Other:~* No other prior malignancy except curatively treated nonmelanomatous skin cancer or superficial bladder cancer~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* See Disease Characteristics~Endocrine therapy:~* Not specified~Radiotherapy:~* Not specified~Surgery:~* Not specified~Other:~* No prior experimental drugs

- Gender: MALE
- Minimum Age: 16 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).